Shanghai Henlius Biotech, Inc.
HKEX:2696.HK
21.45 (HKD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 987.665 | 673.476 | 154.982 | 1,114.309 | 2,301.092 | 958.99 | 58.512 |
| Short Term Investments
| 21.695 | 160.186 | 34.985 | 23.996 | 25.248 | 12.011 | 2.473 |
| Cash and Short Term Investments
| 987.665 | 833.662 | 154.982 | 1,114.309 | 2,301.092 | 958.99 | 58.512 |
| Net Receivables
| 730.247 | 455.509 | 1,072.066 | 196.213 | 29.83 | 7.141 | 19.99 |
| Inventory
| 757.359 | 757.312 | 420.112 | 305.224 | 129.871 | 25.203 | 24.668 |
| Other Current Assets
| 179.066 | 266.848 | -0.001 | 270.252 | 174.658 | 102.792 | 149.716 |
| Total Current Assets
| 2,676.032 | 2,191.542 | 1,647.159 | 1,909.994 | 2,660.699 | 1,086.985 | 232.896 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 2,652.654 | 2,229.871 | 1,667.086 | 1,437.188 | 857.391 | 494.801 | 458.974 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 4,510.729 | 4,332.283 | 3,634.931 | 2,942.454 | 2,175.149 | 1,382.572 | 772.09 |
| Goodwill and Intangible Assets
| 4,510.729 | 4,332.283 | 3,634.931 | 2,942.454 | 2,175.149 | 1,382.572 | 772.09 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 64.156 | 170.612 | 223.668 | 149.54 | 206.578 | 130.432 | 20.557 |
| Total Non-Current Assets
| 7,227.539 | 6,732.766 | 5,525.685 | 4,529.182 | 3,239.118 | 2,007.805 | 1,251.621 |
| Total Assets
| 9,903.571 | 8,924.308 | 7,172.844 | 6,439.176 | 5,899.817 | 3,094.79 | 1,484.517 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 544.815 | 713.552 | 383.47 | 298.952 | 240.158 | 85.309 | 74.2 |
| Short Term Debt
| 2,800.377 | 2,522.155 | 1,570.674 | 1,188.486 | 278.241 | 142.678 | 595.861 |
| Tax Payables
| 83.14 | 20.784 | 21.638 | 6.156 | 2.269 | 1.432 | 0.564 |
| Deferred Revenue
| 1,720.966 | 0 | 987.171 | 484.667 | 0 | 1.432 | 0.564 |
| Other Current Liabilities
| 1.275 | 1,765.871 | 18.41 | 7.403 | 441.238 | 304.024 | 541.025 |
| Total Current Liabilities
| 5,067.433 | 5,001.578 | 2,959.725 | 1,979.508 | 959.637 | 533.443 | 1,211.65 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 1,292.674 | 1,154.94 | 1,052.263 | 645.131 | 331.148 | 385.34 | 162.567 |
| Deferred Revenue Non-Current
| 1,179.092 | 839.088 | 809.675 | 615.765 | 608.617 | 373.458 | 186.29 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 424.197 | 190.43 | -373.458 | -186.29 |
| Other Non-Current Liabilities
| 172.071 | 292.37 | 54.425 | -424.197 | -190.43 | 373.458 | 186.29 |
| Total Non-Current Liabilities
| 2,643.837 | 2,286.398 | 1,916.363 | 1,260.896 | 939.765 | 758.798 | 348.857 |
| Total Liabilities
| 7,711.27 | 7,287.976 | 4,876.088 | 3,240.404 | 1,899.402 | 1,292.241 | 1,560.507 |
| Equity: | |||||||
| Preferred Stock
| 496.108 | 488.431 | 481.101 | 507.781 | 483.304 | 922.172 | 428.486 |
| Common Stock
| 543.495 | 543.495 | 543.495 | 543.495 | 543.495 | 474.433 | 366.287 |
| Retained Earnings
| -3,924.47 | -4,470.489 | -3,775.23 | -2,791.178 | -1,797.637 | -922.172 | -428.486 |
| Accumulated Other Comprehensive Income/Loss
| -496.108 | -488.431 | -481.101 | -507.781 | -483.304 | -98.481 | -60.224 |
| Other Total Stockholders Equity
| 5,573.276 | 5,563.326 | 5,528.491 | 5,446.455 | 5,254.557 | 1,426.597 | -386.137 |
| Total Shareholders Equity
| 2,192.301 | 1,636.332 | 2,296.756 | 3,198.772 | 4,000.415 | 1,802.549 | -80.074 |
| Total Equity
| 2,192.301 | 1,636.332 | 2,296.756 | 3,198.772 | 4,000.415 | 1,802.549 | -75.99 |
| Total Liabilities & Shareholders Equity
| 9,903.571 | 8,924.308 | 7,172.844 | 6,439.176 | 5,899.817 | 3,094.79 | 1,484.517 |